Clinical Trial Update: Fluvastatin in the Therapy of Acute Coronary Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating fluvastatin in patients with acute coronary syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome
• Myocardial Infarction

Drugs mentioned

• Lescol (fluvastatin)

Snippet

Sponsor: Novartis | Conditions: Coronary Disease, Myocardial Infarction | Phase 4 | Status: COMPLETED